Literature DB >> 9750243

A more flexible regression-to-the-mean model with possible stratification.

S Chen1, C Cox, L Cui.   

Abstract

We consider a regression-to-the-mean model that includes both additive and multiplicative treatment effects. We allow either or both of these treatment effects to be stratified by ranges of the first measurement. We focus on the situation where there is a very large sample on the first measurement and a relatively small subsample for the second measurement is selected, which often occurs in screening trials. We propose some asymptotically efficient estimators for the parameters of the model that are very simple to compute. We begin with a discussion of the full model, and more on tests and estimation for reduced models follows. An example from a large screening trial is discussed.

Mesh:

Year:  1998        PMID: 9750243

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  5 in total

1.  Nonparametric regression to the mean.

Authors:  Hans-Georg Muller; Ian Abramson; Rahman Azari
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-05       Impact factor: 11.205

2.  Regression to the mean. A threat to exercise science?

Authors:  Roy J Shephard
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

3.  Baseline cholesterol absorption and the response to ezetimibe/simvastatin therapy: a post-hoc analysis of the ENHANCE trial.

Authors:  L Jakulj; M N Vissers; A K Groen; B A Hutten; D Lutjohann; E P Veltri; J J P Kastelein
Journal:  J Lipid Res       Date:  2009-10-14       Impact factor: 5.922

4.  Combined bias suppression in single-arm therapy studies.

Authors:  Harald J Hamre; Anja Glockmann; Gunver S Kienle; Helmut Kiene
Journal:  J Eval Clin Pract       Date:  2008-03-24       Impact factor: 2.431

5.  An analysis of sickness absence in chronically ill patients receiving complementary and alternative medicine: a longterm prospective intermittent study.

Authors:  Susanne Moebus; Nils Lehmann; Wolfgang Bödeker; Karl-Heinz Jöckel
Journal:  BMC Public Health       Date:  2006-02-12       Impact factor: 3.295

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.